WallStreetZenWallStreetZen

NASDAQ: ENTA
Enanta Pharmaceuticals Inc Stock Ownership - Who owns Enanta Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Enanta Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jay R. LulyPresident and CEO2025-02-127,484$5.59
$41.84kSell
Paul J. MellettChief Fin. Admin Officer2025-02-123,326$5.59
$18.59kSell
Tara Lynn KiefferChief Product Strategy Officer2025-02-123,326$5.59
$18.59kSell
Brendan LuuChief Business Officer2025-02-123,326$5.59
$18.59kSell
Yat Sun OrChief Scientific Officer2025-02-124,324$5.59
$24.17kSell
Scott T. RottinghausChief Medical Officer2025-02-122,861$5.59
$15.99kSell
Jay R. LulyPresident and CEO2025-02-1245,000$5.69
$256.05kBuy
Paul J. MellettChief Fin. Admin Officer2024-12-062,591$8.06
$20.88kSell
Tara Lynn KiefferChief Product Strategy Officer2024-12-062,283$8.06
$18.40kSell
Jay R. LulyPresident and CEO2024-12-065,142$8.06
$41.44kSell

1 of 3

ENTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ENTA insiders and whales buy or sell their stock.

ENTA Shareholders

What type of owners hold Enanta Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Helmut Schuhsler26.95%5,761,609$43.21MInsider
Saints Capital Granite LP16.36%3,497,683$26.23MInsider
Farallon Capital Management LLC9.93%2,122,262$15.92MInstitution
Krensavage Asset Management LLC9.90%2,116,586$15.87MInstitution
Blackrock Inc9.44%2,018,669$15.14MInstitution
Vanguard Group Inc9.39%2,007,433$15.06MInstitution
Shionogi Co Ltd7.48%1,599,760$12.00MInsider
Millennium Management LLC6.30%1,346,932$10.10MInstitution
Tvm V Life Science Ventures Gmbh Co Kg5.36%1,144,932$8.59MInsider
Acadian Asset Management LLC4.06%867,037$6.50MInstitution

1 of 3

ENTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENTA56.75%43.25%Net Selling
VXRT11.96%54.78%Net BuyingNet Buying
IPHA0.19%0.00%
SPRO27.02%64.19%Net Selling
DMAC17.52%64.28%Net BuyingNet Buying
View Top Biotech Stocks

Enanta Pharmaceuticals Stock Ownership FAQ

Who owns Enanta Pharmaceuticals?

Enanta Pharmaceuticals (NASDAQ: ENTA) is owned by 87.13% institutional shareholders, 66.40% Enanta Pharmaceuticals insiders, and 0.00% retail investors. Helmut Schuhsler is the largest individual Enanta Pharmaceuticals shareholder, owning 5.76M shares representing 26.95% of the company. Helmut Schuhsler's Enanta Pharmaceuticals shares are currently valued at $43.21M.

If you're new to stock investing, here's how to buy Enanta Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.